AbbVie Inc. (LON:0QCV)
London · Delayed Price · Currency is GBP · Price in USD 221.20
-3.64 (-1.62%)
At close: Jan 9, 2026
AbbVie Market Cap
AbbVie has a market cap or net worth of 290.15 billion as of January 9, 2026. Its market cap has increased by 15.19% in one year.
Market Cap
290.15B
Enterprise Value
337.31B
Revenue
44.37B
Ranking
n/a
PE Ratio
166.11
Stock Price
221.20
Market Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 34.43B to 290.15B, an increase of 742.71%. That is a compound annual growth rate of 17.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 290.15B | -3.30% |
| Dec 31, 2025 | 300.05B | 19.62% |
| Dec 31, 2024 | 250.83B | 16.77% |
| Dec 29, 2023 | 214.80B | -9.41% |
| Dec 30, 2022 | 237.12B | 34.13% |
| Dec 31, 2021 | 176.78B | 27.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| GSK plc | 75.87B |
| Haleon | 33.12B |
| Smith & Nephew | 10.78B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.72B |